• NEW pathogen-reduced human platelet lysate

  • No heparin added during production or required for use

  • Available in 100mL and 500mL bottles for easy handling

  • Ample supply to meet your large-scale commercialization needs

nLiven PR

PATHOGEN-REDUCED HUMAN PLATELET LYSATE

Vital to Clinical Progress

nLiven PR is a human platelet lysate (HPL) using a unique pathogen-reduction process that is GMP compliant. It is designed to meet your needs for the evolving global regulations and challenging development milestones. nLiven PR is your tool to develop therapeutics by providing:

  • Safety: validated pathogen reduction in an ISO 9001 certified facility and tested for sterility, mycoplasma, and endotoxin
  • Reproducibility: minimized lot-to-lot variability by pooling over 100 human U.S. donors from AABB accredited/FDA registered blood centers
  • Reliability: established manufacturer, dependable supply to meet your large-scale commercialization needs, and stable pricing
  • Compliance: produced under consideration of European Pharmacopoeia General Chapter 5.2.12.4

nLiven PR, vital to clinical progress.

FREE SAMPLE

Request a free sample bottle of nLiven PR for evaluation.

 

Ordering Information

ProductPart Number
nLiven PR 100mLPL-PR-100
nLiven PR 500mLPL-PR-500

NOTE: No heparin added during production or required for use


Disclaimer:
nLiven PR shown on this website is not approved or available in all regulatory jurisdictions. Please consult with your local Cook Regentec representative or Customer Service for details.

Not all products shown on this website may be approved in all regulatory jurisdictions. Consult with your local Cook Regentec representative, distribution company, or Customer Service for details.